Medical Care
Global Human Microbiome Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Mar 24, 25
- ID: 147148
- Pages: 109
- Figures: 106
- Views: 47
The global Human Microbiome market size was US$ 568 million in 2024 and is forecast to a readjusted size of US$ 2207 million by 2031 with a CAGR of 21.7% during the forecast period 2025-2031.
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that"s 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
The global Human Microbiome market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
By Type: (Dominant Segment vs High-Margin Innovation)
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Treatment
Diagnosis
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Vedanta in Europe)
- Emerging Product Trends: Gastrointestinal Tract Human Micobiome adoption vs. Urogenital Tract Human Micobiome premiumization
- Demand-Side Dynamics: Treatment growth in China vs. Diagnosis potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Human Microbiome market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Urogenital Tract Human Micobiome in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Diagnosis in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Human Microbiome value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that"s 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
The global Human Microbiome market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC
By Type: (Dominant Segment vs High-Margin Innovation)
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Treatment
Diagnosis
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Vedanta in Europe)
- Emerging Product Trends: Gastrointestinal Tract Human Micobiome adoption vs. Urogenital Tract Human Micobiome premiumization
- Demand-Side Dynamics: Treatment growth in China vs. Diagnosis potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Human Microbiome market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Urogenital Tract Human Micobiome in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Diagnosis in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Human Microbiome value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Gastrointestinal Tract Human Micobiome
1.2.3 Urogenital Tract Human Micobiome
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Human Microbiome Revenue Market Share by Region (2020-2025)
2.4 Global Human Microbiome Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Human Microbiome Market Size and Prospective (2020-2031)
2.5.2 Europe Human Microbiome Market Size and Prospective (2020-2031)
2.5.3 China Human Microbiome Market Size and Prospective (2020-2031)
2.5.4 Japan Human Microbiome Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Human Microbiome Market Size and Prospective (2020-2031)
2.5.6 India Human Microbiome Market Size and Prospective (2020-2031)
2.5.7 Central & South America Human Microbiome Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Human Microbiome Historic Market Size by Type (2020-2025)
3.2 Global Human Microbiome Forecasted Market Size by Type (2026-2031)
3.3 Different Types Human Microbiome Representative Players
4 Breakdown Data by Application
4.1 Global Human Microbiome Historic Market Size by Application (2020-2025)
4.2 Global Human Microbiome Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Human Microbiome Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Human Microbiome Players by Revenue (2020-2025)
5.1.2 Global Human Microbiome Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Human Microbiome Revenue
5.4 Global Human Microbiome Market Concentration Analysis
5.4.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2024
5.5 Global Key Players of Human Microbiome Head office and Area Served
5.6 Global Key Players of Human Microbiome, Product and Application
5.7 Global Key Players of Human Microbiome, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Human Microbiome Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Human Microbiome Market Size by Type (2020-2025)
6.1.2.2 North America Human Microbiome Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Human Microbiome Market Size by Application (2020-2025)
6.1.3.2 North America Human Microbiome Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Human Microbiome Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Human Microbiome Market Size by Type (2020-2025)
6.2.2.2 Europe Human Microbiome Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Human Microbiome Market Size by Application (2020-2025)
6.2.3.2 Europe Human Microbiome Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Human Microbiome Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Human Microbiome Market Size by Type (2020-2025)
6.3.2.2 China Human Microbiome Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Human Microbiome Market Size by Application (2020-2025)
6.3.3.2 China Human Microbiome Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Human Microbiome Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Human Microbiome Market Size by Type (2020-2025)
6.4.2.2 Japan Human Microbiome Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Human Microbiome Market Size by Application (2020-2025)
6.4.3.2 Japan Human Microbiome Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Human Microbiome Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Human Microbiome Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Human Microbiome Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Human Microbiome Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Human Microbiome Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Human Microbiome Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Human Microbiome Market Size by Type (2020-2025)
6.6.2.2 India Human Microbiome Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Human Microbiome Market Size by Application (2020-2025)
6.6.3.2 India Human Microbiome Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Vedanta
7.1.1 Vedanta Company Details
7.1.2 Vedanta Business Overview
7.1.3 Vedanta Human Microbiome Introduction
7.1.4 Vedanta Revenue in Human Microbiome Business (2020-2025)
7.1.5 Vedanta Recent Development
7.2 Seres Therapeutics
7.2.1 Seres Therapeutics Company Details
7.2.2 Seres Therapeutics Business Overview
7.2.3 Seres Therapeutics Human Microbiome Introduction
7.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2020-2025)
7.2.5 Seres Therapeutics Recent Development
7.3 Second Genome
7.3.1 Second Genome Company Details
7.3.2 Second Genome Business Overview
7.3.3 Second Genome Human Microbiome Introduction
7.3.4 Second Genome Revenue in Human Microbiome Business (2020-2025)
7.3.5 Second Genome Recent Development
7.4 Rebiotix
7.4.1 Rebiotix Company Details
7.4.2 Rebiotix Business Overview
7.4.3 Rebiotix Human Microbiome Introduction
7.4.4 Rebiotix Revenue in Human Microbiome Business (2020-2025)
7.4.5 Rebiotix Recent Development
7.5 ActoGeniX
7.5.1 ActoGeniX Company Details
7.5.2 ActoGeniX Business Overview
7.5.3 ActoGeniX Human Microbiome Introduction
7.5.4 ActoGeniX Revenue in Human Microbiome Business (2020-2025)
7.5.5 ActoGeniX Recent Development
7.6 Enterome BioScience
7.6.1 Enterome BioScience Company Details
7.6.2 Enterome BioScience Business Overview
7.6.3 Enterome BioScience Human Microbiome Introduction
7.6.4 Enterome BioScience Revenue in Human Microbiome Business (2020-2025)
7.6.5 Enterome BioScience Recent Development
7.7 AvidBiotics
7.7.1 AvidBiotics Company Details
7.7.2 AvidBiotics Business Overview
7.7.3 AvidBiotics Human Microbiome Introduction
7.7.4 AvidBiotics Revenue in Human Microbiome Business (2020-2025)
7.7.5 AvidBiotics Recent Development
7.8 4D Pharma Research Ltd
7.8.1 4D Pharma Research Ltd Company Details
7.8.2 4D Pharma Research Ltd Business Overview
7.8.3 4D Pharma Research Ltd Human Microbiome Introduction
7.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2020-2025)
7.8.5 4D Pharma Research Ltd Recent Development
7.9 Enterologics
7.9.1 Enterologics Company Details
7.9.2 Enterologics Business Overview
7.9.3 Enterologics Human Microbiome Introduction
7.9.4 Enterologics Revenue in Human Microbiome Business (2020-2025)
7.9.5 Enterologics Recent Development
7.10 Metabogen
7.10.1 Metabogen Company Details
7.10.2 Metabogen Business Overview
7.10.3 Metabogen Human Microbiome Introduction
7.10.4 Metabogen Revenue in Human Microbiome Business (2020-2025)
7.10.5 Metabogen Recent Development
7.11 Metabiomics
7.11.1 Metabiomics Company Details
7.11.2 Metabiomics Business Overview
7.11.3 Metabiomics Human Microbiome Introduction
7.11.4 Metabiomics Revenue in Human Microbiome Business (2020-2025)
7.11.5 Metabiomics Recent Development
7.12 Ritter Pharmaceuticals
7.12.1 Ritter Pharmaceuticals Company Details
7.12.2 Ritter Pharmaceuticals Business Overview
7.12.3 Ritter Pharmaceuticals Human Microbiome Introduction
7.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2020-2025)
7.12.5 Ritter Pharmaceuticals Recent Development
7.13 Osel
7.13.1 Osel Company Details
7.13.2 Osel Business Overview
7.13.3 Osel Human Microbiome Introduction
7.13.4 Osel Revenue in Human Microbiome Business (2020-2025)
7.13.5 Osel Recent Development
7.14 Symberix
7.14.1 Symberix Company Details
7.14.2 Symberix Business Overview
7.14.3 Symberix Human Microbiome Introduction
7.14.4 Symberix Revenue in Human Microbiome Business (2020-2025)
7.14.5 Symberix Recent Development
7.15 Miomics
7.15.1 Miomics Company Details
7.15.2 Miomics Business Overview
7.15.3 Miomics Human Microbiome Introduction
7.15.4 Miomics Revenue in Human Microbiome Business (2020-2025)
7.15.5 Miomics Recent Development
7.16 Symbiotix Biotherapies
7.16.1 Symbiotix Biotherapies Company Details
7.16.2 Symbiotix Biotherapies Business Overview
7.16.3 Symbiotix Biotherapies Human Microbiome Introduction
7.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2020-2025)
7.16.5 Symbiotix Biotherapies Recent Development
7.17 MicroBiome Therapeutics LLC
7.17.1 MicroBiome Therapeutics LLC Company Details
7.17.2 MicroBiome Therapeutics LLC Business Overview
7.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction
7.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2020-2025)
7.17.5 MicroBiome Therapeutics LLC Recent Development
8 Human Microbiome Market Dynamics
8.1 Human Microbiome Industry Trends
8.2 Human Microbiome Market Drivers
8.3 Human Microbiome Market Challenges
8.4 Human Microbiome Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Gastrointestinal Tract Human Micobiome
1.2.3 Urogenital Tract Human Micobiome
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Human Microbiome Revenue Market Share by Region (2020-2025)
2.4 Global Human Microbiome Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Human Microbiome Market Size and Prospective (2020-2031)
2.5.2 Europe Human Microbiome Market Size and Prospective (2020-2031)
2.5.3 China Human Microbiome Market Size and Prospective (2020-2031)
2.5.4 Japan Human Microbiome Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Human Microbiome Market Size and Prospective (2020-2031)
2.5.6 India Human Microbiome Market Size and Prospective (2020-2031)
2.5.7 Central & South America Human Microbiome Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Human Microbiome Historic Market Size by Type (2020-2025)
3.2 Global Human Microbiome Forecasted Market Size by Type (2026-2031)
3.3 Different Types Human Microbiome Representative Players
4 Breakdown Data by Application
4.1 Global Human Microbiome Historic Market Size by Application (2020-2025)
4.2 Global Human Microbiome Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Human Microbiome Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Human Microbiome Players by Revenue (2020-2025)
5.1.2 Global Human Microbiome Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Human Microbiome Revenue
5.4 Global Human Microbiome Market Concentration Analysis
5.4.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2024
5.5 Global Key Players of Human Microbiome Head office and Area Served
5.6 Global Key Players of Human Microbiome, Product and Application
5.7 Global Key Players of Human Microbiome, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Human Microbiome Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Human Microbiome Market Size by Type (2020-2025)
6.1.2.2 North America Human Microbiome Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Human Microbiome Market Size by Application (2020-2025)
6.1.3.2 North America Human Microbiome Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Human Microbiome Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Human Microbiome Market Size by Type (2020-2025)
6.2.2.2 Europe Human Microbiome Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Human Microbiome Market Size by Application (2020-2025)
6.2.3.2 Europe Human Microbiome Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Human Microbiome Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Human Microbiome Market Size by Type (2020-2025)
6.3.2.2 China Human Microbiome Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Human Microbiome Market Size by Application (2020-2025)
6.3.3.2 China Human Microbiome Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Human Microbiome Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Human Microbiome Market Size by Type (2020-2025)
6.4.2.2 Japan Human Microbiome Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Human Microbiome Market Size by Application (2020-2025)
6.4.3.2 Japan Human Microbiome Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Human Microbiome Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Human Microbiome Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Human Microbiome Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Human Microbiome Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Human Microbiome Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Human Microbiome Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Human Microbiome Market Size by Type (2020-2025)
6.6.2.2 India Human Microbiome Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Human Microbiome Market Size by Application (2020-2025)
6.6.3.2 India Human Microbiome Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Vedanta
7.1.1 Vedanta Company Details
7.1.2 Vedanta Business Overview
7.1.3 Vedanta Human Microbiome Introduction
7.1.4 Vedanta Revenue in Human Microbiome Business (2020-2025)
7.1.5 Vedanta Recent Development
7.2 Seres Therapeutics
7.2.1 Seres Therapeutics Company Details
7.2.2 Seres Therapeutics Business Overview
7.2.3 Seres Therapeutics Human Microbiome Introduction
7.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2020-2025)
7.2.5 Seres Therapeutics Recent Development
7.3 Second Genome
7.3.1 Second Genome Company Details
7.3.2 Second Genome Business Overview
7.3.3 Second Genome Human Microbiome Introduction
7.3.4 Second Genome Revenue in Human Microbiome Business (2020-2025)
7.3.5 Second Genome Recent Development
7.4 Rebiotix
7.4.1 Rebiotix Company Details
7.4.2 Rebiotix Business Overview
7.4.3 Rebiotix Human Microbiome Introduction
7.4.4 Rebiotix Revenue in Human Microbiome Business (2020-2025)
7.4.5 Rebiotix Recent Development
7.5 ActoGeniX
7.5.1 ActoGeniX Company Details
7.5.2 ActoGeniX Business Overview
7.5.3 ActoGeniX Human Microbiome Introduction
7.5.4 ActoGeniX Revenue in Human Microbiome Business (2020-2025)
7.5.5 ActoGeniX Recent Development
7.6 Enterome BioScience
7.6.1 Enterome BioScience Company Details
7.6.2 Enterome BioScience Business Overview
7.6.3 Enterome BioScience Human Microbiome Introduction
7.6.4 Enterome BioScience Revenue in Human Microbiome Business (2020-2025)
7.6.5 Enterome BioScience Recent Development
7.7 AvidBiotics
7.7.1 AvidBiotics Company Details
7.7.2 AvidBiotics Business Overview
7.7.3 AvidBiotics Human Microbiome Introduction
7.7.4 AvidBiotics Revenue in Human Microbiome Business (2020-2025)
7.7.5 AvidBiotics Recent Development
7.8 4D Pharma Research Ltd
7.8.1 4D Pharma Research Ltd Company Details
7.8.2 4D Pharma Research Ltd Business Overview
7.8.3 4D Pharma Research Ltd Human Microbiome Introduction
7.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2020-2025)
7.8.5 4D Pharma Research Ltd Recent Development
7.9 Enterologics
7.9.1 Enterologics Company Details
7.9.2 Enterologics Business Overview
7.9.3 Enterologics Human Microbiome Introduction
7.9.4 Enterologics Revenue in Human Microbiome Business (2020-2025)
7.9.5 Enterologics Recent Development
7.10 Metabogen
7.10.1 Metabogen Company Details
7.10.2 Metabogen Business Overview
7.10.3 Metabogen Human Microbiome Introduction
7.10.4 Metabogen Revenue in Human Microbiome Business (2020-2025)
7.10.5 Metabogen Recent Development
7.11 Metabiomics
7.11.1 Metabiomics Company Details
7.11.2 Metabiomics Business Overview
7.11.3 Metabiomics Human Microbiome Introduction
7.11.4 Metabiomics Revenue in Human Microbiome Business (2020-2025)
7.11.5 Metabiomics Recent Development
7.12 Ritter Pharmaceuticals
7.12.1 Ritter Pharmaceuticals Company Details
7.12.2 Ritter Pharmaceuticals Business Overview
7.12.3 Ritter Pharmaceuticals Human Microbiome Introduction
7.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2020-2025)
7.12.5 Ritter Pharmaceuticals Recent Development
7.13 Osel
7.13.1 Osel Company Details
7.13.2 Osel Business Overview
7.13.3 Osel Human Microbiome Introduction
7.13.4 Osel Revenue in Human Microbiome Business (2020-2025)
7.13.5 Osel Recent Development
7.14 Symberix
7.14.1 Symberix Company Details
7.14.2 Symberix Business Overview
7.14.3 Symberix Human Microbiome Introduction
7.14.4 Symberix Revenue in Human Microbiome Business (2020-2025)
7.14.5 Symberix Recent Development
7.15 Miomics
7.15.1 Miomics Company Details
7.15.2 Miomics Business Overview
7.15.3 Miomics Human Microbiome Introduction
7.15.4 Miomics Revenue in Human Microbiome Business (2020-2025)
7.15.5 Miomics Recent Development
7.16 Symbiotix Biotherapies
7.16.1 Symbiotix Biotherapies Company Details
7.16.2 Symbiotix Biotherapies Business Overview
7.16.3 Symbiotix Biotherapies Human Microbiome Introduction
7.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2020-2025)
7.16.5 Symbiotix Biotherapies Recent Development
7.17 MicroBiome Therapeutics LLC
7.17.1 MicroBiome Therapeutics LLC Company Details
7.17.2 MicroBiome Therapeutics LLC Business Overview
7.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction
7.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2020-2025)
7.17.5 MicroBiome Therapeutics LLC Recent Development
8 Human Microbiome Market Dynamics
8.1 Human Microbiome Industry Trends
8.2 Human Microbiome Market Drivers
8.3 Human Microbiome Market Challenges
8.4 Human Microbiome Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Human Microbiome Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Human Microbiome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Human Microbiome Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Human Microbiome Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Human Microbiome Revenue Share by Region (2020-2025)
Table 6. Global Human Microbiome Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Human Microbiome Revenue Share Forecast by Region (2026-2031)
Table 8. Global Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Human Microbiome Revenue Market Share by Type (2020-2025)
Table 10. Global Human Microbiome Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Human Microbiome Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Human Microbiome Revenue Market Share by Application (2020-2025)
Table 15. Global Human Microbiome Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Human Microbiome Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Human Microbiome Application
Table 18. Global Human Microbiome Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Human Microbiome Market Share by Players (2020-2025)
Table 20. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2024)
Table 21. Ranking of Global Top Human Microbiome Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Human Microbiome Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Human Microbiome, Headquarters and Area Served
Table 24. Global Key Players of Human Microbiome, Product and Application
Table 25. Global Key Players of Human Microbiome, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Human Microbiome Revenue Market Share by Company (2020-2025)
Table 29. North America Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Human Microbiome Revenue Market Share by Company (2020-2025)
Table 33. Europe Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Human Microbiome Revenue Market Share by Company (2020-2025)
Table 37. China Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Human Microbiome Revenue Market Share by Company (2020-2025)
Table 41. Japan Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Human Microbiome Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Human Microbiome Revenue Market Share by Company (2020-2025)
Table 49. India Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 51. Vedanta Company Details
Table 52. Vedanta Business Overview
Table 53. Vedanta Human Microbiome Product
Table 54. Vedanta Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 55. Vedanta Recent Development
Table 56. Seres Therapeutics Company Details
Table 57. Seres Therapeutics Business Overview
Table 58. Seres Therapeutics Human Microbiome Product
Table 59. Seres Therapeutics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 60. Seres Therapeutics Recent Development
Table 61. Second Genome Company Details
Table 62. Second Genome Business Overview
Table 63. Second Genome Human Microbiome Product
Table 64. Second Genome Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 65. Second Genome Recent Development
Table 66. Rebiotix Company Details
Table 67. Rebiotix Business Overview
Table 68. Rebiotix Human Microbiome Product
Table 69. Rebiotix Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 70. Rebiotix Recent Development
Table 71. ActoGeniX Company Details
Table 72. ActoGeniX Business Overview
Table 73. ActoGeniX Human Microbiome Product
Table 74. ActoGeniX Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 75. ActoGeniX Recent Development
Table 76. Enterome BioScience Company Details
Table 77. Enterome BioScience Business Overview
Table 78. Enterome BioScience Human Microbiome Product
Table 79. Enterome BioScience Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 80. Enterome BioScience Recent Development
Table 81. AvidBiotics Company Details
Table 82. AvidBiotics Business Overview
Table 83. AvidBiotics Human Microbiome Product
Table 84. AvidBiotics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 85. AvidBiotics Recent Development
Table 86. 4D Pharma Research Ltd Company Details
Table 87. 4D Pharma Research Ltd Business Overview
Table 88. 4D Pharma Research Ltd Human Microbiome Product
Table 89. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 90. 4D Pharma Research Ltd Recent Development
Table 91. Enterologics Company Details
Table 92. Enterologics Business Overview
Table 93. Enterologics Human Microbiome Product
Table 94. Enterologics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 95. Enterologics Recent Development
Table 96. Metabogen Company Details
Table 97. Metabogen Business Overview
Table 98. Metabogen Human Microbiome Product
Table 99. Metabogen Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 100. Metabogen Recent Development
Table 101. Metabiomics Company Details
Table 102. Metabiomics Business Overview
Table 103. Metabiomics Human Microbiome Product
Table 104. Metabiomics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 105. Metabiomics Recent Development
Table 106. Ritter Pharmaceuticals Company Details
Table 107. Ritter Pharmaceuticals Business Overview
Table 108. Ritter Pharmaceuticals Human Microbiome Product
Table 109. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 110. Ritter Pharmaceuticals Recent Development
Table 111. Osel Company Details
Table 112. Osel Business Overview
Table 113. Osel Human Microbiome Product
Table 114. Osel Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 115. Osel Recent Development
Table 116. Symberix Company Details
Table 117. Symberix Business Overview
Table 118. Symberix Human Microbiome Product
Table 119. Symberix Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 120. Symberix Recent Development
Table 121. Miomics Company Details
Table 122. Miomics Business Overview
Table 123. Miomics Human Microbiome Product
Table 124. Miomics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 125. Miomics Recent Development
Table 126. Symbiotix Biotherapies Company Details
Table 127. Symbiotix Biotherapies Business Overview
Table 128. Symbiotix Biotherapies Human Microbiome Product
Table 129. Symbiotix Biotherapies Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 130. Symbiotix Biotherapies Recent Development
Table 131. MicroBiome Therapeutics LLC Company Details
Table 132. MicroBiome Therapeutics LLC Business Overview
Table 133. MicroBiome Therapeutics LLC Human Microbiome Product
Table 134. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 135. MicroBiome Therapeutics LLC Recent Development
Table 136. Human Microbiome Market Trends
Table 137. Human Microbiome Market Drivers
Table 138. Human Microbiome Market Challenges
Table 139. Human Microbiome Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Microbiome Product Picture
Figure 2. Global Human Microbiome Market Share by Type: 2024 VS 2031
Figure 3. Gastrointestinal Tract Human Micobiome Features
Figure 4. Urogenital Tract Human Micobiome Features
Figure 5. Others Features
Figure 6. Global Human Microbiome Market Share by Application: 2024 VS 2031
Figure 7. Treatment
Figure 8. Diagnosis
Figure 9. Human Microbiome Report Years Considered
Figure 10. Global Human Microbiome Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Human Microbiome Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Human Microbiome Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Southeast Asia Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. India Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Central & South America Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Human Microbiome Market Share by Players in 2024
Figure 21. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2024
Figure 23. North America Human Microbiome Market Share by Type (2020-2025)
Figure 24. North America Human Microbiome Market Share by Application (2020-2025)
Figure 25. Europe Human Microbiome Market Share by Type (2020-2025)
Figure 26. Europe Human Microbiome Market Share by Application (2020-2025)
Figure 27. China Human Microbiome Market Share by Type (2020-2025)
Figure 28. China Human Microbiome Market Share by Application (2020-2025)
Figure 29. Japan Human Microbiome Market Share by Type (2020-2025)
Figure 30. Japan Human Microbiome Market Share by Application (2020-2025)
Figure 31. Southeast Asia Human Microbiome Market Share by Type (2020-2025)
Figure 32. Southeast Asia Human Microbiome Market Share by Application (2020-2025)
Figure 33. India Human Microbiome Market Share by Type (2020-2025)
Figure 34. India Human Microbiome Market Share by Application (2020-2025)
Figure 35. Vedanta Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 36. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 37. Second Genome Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 38. Rebiotix Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 39. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 40. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 41. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 42. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 43. Enterologics Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 44. Metabogen Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 45. Metabiomics Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 46. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 47. Osel Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 48. Symberix Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 49. Miomics Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 50. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 51. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Table 1. Global Human Microbiome Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Human Microbiome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Human Microbiome Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Human Microbiome Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Human Microbiome Revenue Share by Region (2020-2025)
Table 6. Global Human Microbiome Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Human Microbiome Revenue Share Forecast by Region (2026-2031)
Table 8. Global Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Human Microbiome Revenue Market Share by Type (2020-2025)
Table 10. Global Human Microbiome Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Human Microbiome Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Human Microbiome Revenue Market Share by Application (2020-2025)
Table 15. Global Human Microbiome Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Human Microbiome Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Human Microbiome Application
Table 18. Global Human Microbiome Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Human Microbiome Market Share by Players (2020-2025)
Table 20. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2024)
Table 21. Ranking of Global Top Human Microbiome Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Human Microbiome Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Human Microbiome, Headquarters and Area Served
Table 24. Global Key Players of Human Microbiome, Product and Application
Table 25. Global Key Players of Human Microbiome, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Human Microbiome Revenue Market Share by Company (2020-2025)
Table 29. North America Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Human Microbiome Revenue Market Share by Company (2020-2025)
Table 33. Europe Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Human Microbiome Revenue Market Share by Company (2020-2025)
Table 37. China Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Human Microbiome Revenue Market Share by Company (2020-2025)
Table 41. Japan Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Human Microbiome Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Human Microbiome Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Human Microbiome Revenue Market Share by Company (2020-2025)
Table 49. India Human Microbiome Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Human Microbiome Market Size by Application (2020-2025) & (US$ Million)
Table 51. Vedanta Company Details
Table 52. Vedanta Business Overview
Table 53. Vedanta Human Microbiome Product
Table 54. Vedanta Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 55. Vedanta Recent Development
Table 56. Seres Therapeutics Company Details
Table 57. Seres Therapeutics Business Overview
Table 58. Seres Therapeutics Human Microbiome Product
Table 59. Seres Therapeutics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 60. Seres Therapeutics Recent Development
Table 61. Second Genome Company Details
Table 62. Second Genome Business Overview
Table 63. Second Genome Human Microbiome Product
Table 64. Second Genome Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 65. Second Genome Recent Development
Table 66. Rebiotix Company Details
Table 67. Rebiotix Business Overview
Table 68. Rebiotix Human Microbiome Product
Table 69. Rebiotix Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 70. Rebiotix Recent Development
Table 71. ActoGeniX Company Details
Table 72. ActoGeniX Business Overview
Table 73. ActoGeniX Human Microbiome Product
Table 74. ActoGeniX Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 75. ActoGeniX Recent Development
Table 76. Enterome BioScience Company Details
Table 77. Enterome BioScience Business Overview
Table 78. Enterome BioScience Human Microbiome Product
Table 79. Enterome BioScience Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 80. Enterome BioScience Recent Development
Table 81. AvidBiotics Company Details
Table 82. AvidBiotics Business Overview
Table 83. AvidBiotics Human Microbiome Product
Table 84. AvidBiotics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 85. AvidBiotics Recent Development
Table 86. 4D Pharma Research Ltd Company Details
Table 87. 4D Pharma Research Ltd Business Overview
Table 88. 4D Pharma Research Ltd Human Microbiome Product
Table 89. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 90. 4D Pharma Research Ltd Recent Development
Table 91. Enterologics Company Details
Table 92. Enterologics Business Overview
Table 93. Enterologics Human Microbiome Product
Table 94. Enterologics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 95. Enterologics Recent Development
Table 96. Metabogen Company Details
Table 97. Metabogen Business Overview
Table 98. Metabogen Human Microbiome Product
Table 99. Metabogen Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 100. Metabogen Recent Development
Table 101. Metabiomics Company Details
Table 102. Metabiomics Business Overview
Table 103. Metabiomics Human Microbiome Product
Table 104. Metabiomics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 105. Metabiomics Recent Development
Table 106. Ritter Pharmaceuticals Company Details
Table 107. Ritter Pharmaceuticals Business Overview
Table 108. Ritter Pharmaceuticals Human Microbiome Product
Table 109. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 110. Ritter Pharmaceuticals Recent Development
Table 111. Osel Company Details
Table 112. Osel Business Overview
Table 113. Osel Human Microbiome Product
Table 114. Osel Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 115. Osel Recent Development
Table 116. Symberix Company Details
Table 117. Symberix Business Overview
Table 118. Symberix Human Microbiome Product
Table 119. Symberix Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 120. Symberix Recent Development
Table 121. Miomics Company Details
Table 122. Miomics Business Overview
Table 123. Miomics Human Microbiome Product
Table 124. Miomics Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 125. Miomics Recent Development
Table 126. Symbiotix Biotherapies Company Details
Table 127. Symbiotix Biotherapies Business Overview
Table 128. Symbiotix Biotherapies Human Microbiome Product
Table 129. Symbiotix Biotherapies Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 130. Symbiotix Biotherapies Recent Development
Table 131. MicroBiome Therapeutics LLC Company Details
Table 132. MicroBiome Therapeutics LLC Business Overview
Table 133. MicroBiome Therapeutics LLC Human Microbiome Product
Table 134. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2020-2025) & (US$ Million)
Table 135. MicroBiome Therapeutics LLC Recent Development
Table 136. Human Microbiome Market Trends
Table 137. Human Microbiome Market Drivers
Table 138. Human Microbiome Market Challenges
Table 139. Human Microbiome Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Microbiome Product Picture
Figure 2. Global Human Microbiome Market Share by Type: 2024 VS 2031
Figure 3. Gastrointestinal Tract Human Micobiome Features
Figure 4. Urogenital Tract Human Micobiome Features
Figure 5. Others Features
Figure 6. Global Human Microbiome Market Share by Application: 2024 VS 2031
Figure 7. Treatment
Figure 8. Diagnosis
Figure 9. Human Microbiome Report Years Considered
Figure 10. Global Human Microbiome Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Human Microbiome Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Human Microbiome Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Southeast Asia Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. India Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Central & South America Human Microbiome Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Human Microbiome Market Share by Players in 2024
Figure 21. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2024
Figure 23. North America Human Microbiome Market Share by Type (2020-2025)
Figure 24. North America Human Microbiome Market Share by Application (2020-2025)
Figure 25. Europe Human Microbiome Market Share by Type (2020-2025)
Figure 26. Europe Human Microbiome Market Share by Application (2020-2025)
Figure 27. China Human Microbiome Market Share by Type (2020-2025)
Figure 28. China Human Microbiome Market Share by Application (2020-2025)
Figure 29. Japan Human Microbiome Market Share by Type (2020-2025)
Figure 30. Japan Human Microbiome Market Share by Application (2020-2025)
Figure 31. Southeast Asia Human Microbiome Market Share by Type (2020-2025)
Figure 32. Southeast Asia Human Microbiome Market Share by Application (2020-2025)
Figure 33. India Human Microbiome Market Share by Type (2020-2025)
Figure 34. India Human Microbiome Market Share by Application (2020-2025)
Figure 35. Vedanta Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 36. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 37. Second Genome Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 38. Rebiotix Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 39. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 40. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 41. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 42. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 43. Enterologics Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 44. Metabogen Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 45. Metabiomics Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 46. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 47. Osel Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 48. Symberix Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 49. Miomics Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 50. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 51. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232